This inventor holds 2 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1982-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (1982)
- Shizuoka, JP (2003)
Company Filing History:
Years Active: 1982-2003
Title: Innovations of Toshio Kuroki
Introduction
Toshio Kuroki is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical use. With a total of 2 patents to his name, Kuroki's work has had a meaningful impact on the industry.
Latest Patents
Kuroki's latest patents include advancements in methotrexate derivatives, which serve as antirheumatic agents. These compounds are characterized by a general formula that includes α-substituted ureido-benzylpenicillanic acids. The acids and their pharmaceutically acceptable salts exhibit high antibacterial activities against both Gram-positive and Gram-negative bacteria, especially those of the genus Pseudomonas. This innovation highlights Kuroki's commitment to addressing critical health challenges through his research.
Career Highlights
Throughout his career, Toshio Kuroki has been associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has allowed him to focus on developing effective treatments that can improve patient outcomes. Kuroki's dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Kuroki has collaborated with esteemed colleagues such as Hiroharu Matsuoka and Hiroshi Suzuki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Toshio Kuroki's contributions to pharmaceutical innovations demonstrate his expertise and commitment to improving healthcare. His patents reflect a deep understanding of medicinal chemistry and a desire to create effective treatments for various ailments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
